Close
Help




JOURNAL

Clinical Medicine Insights: Reproductive Health

Ovarian Stem Cells-the Pros and Cons

Submit a Paper


Clinical Medicine Insights: Reproductive Health 2013:7 43-47

Perspective

Published on 20 Mar 2013

DOI: 10.4137/CMRH.S11086


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Reproductive Health

Abstract

The potential for postnatal de novo oogenesis in mammals and in humans has become very controversial in the fields of reproductive science and biology.

Historically, it has been thought that females of most mammalian species lose the ability to produce oocytes at birth. A contemporary understanding of stem cell biology together with novel experimental methods has challenged the model of a prenatal fixed ovarian primordial follicle pool that declines with age. Researchers have suggested replenishment of post-natal oocytes by germ-line stem cells (GSCs). According to this theory, GSCs produce oocytes and primordial follicles throughout the lifetime of the adult female.

This review describes recent approaches supporting the revolutionary idea of de novo oogenesis in mammals and humans of reproductive-age and provides counter arguments from opponents of this novel and innovative concept.



Downloads

PDF  (578.60 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Reproductive Health
As the Editor-in-Chief of Clinical Medicine Insights: Reproductive Health, I experience outstanding professional and friendly assistance by the publisher, Libertas Academica, in all editorial matters.
Zeev Blumenfeld (Rappaport Institute, Technion, Faculty of Medicine, Haifa, Israel)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube